Skip to search formSkip to main contentSkip to account menu

NSC-32946

Known as: NSC 32946, NSC32946 
National Institutes of Health

Related topics

Related topics

2 relations
Methyl-gag

Broader (1)

Mitoguazone

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1982
1982
Phase II studies of methyl glyoxal bis‐guanylhydrazone (NSC 32946) in carcinoma of the colon and lung
We have tested methyl glyoxal bis‐guanyl hydrazone (NSC 32946) for antitumor activity in patients with colorectal carcinoma and… 
1982
1982
Phase II trial of methyl‐GAG (NSC‐32946) in squamous cell and adenocarcinoma of the lung
THIRTY-FOUR ASSESSABLE PATIENTS with advanced squamous cell and adenocarcinoma of the lung were treated with weekly MGBG in a… 
1980
1980
High-performance liquid chromatographic analysis of the anticancer agent methylglyoxal bis(guanylhydrazone) (MGBG, NSC-32946) in biological fluids.
1977
1977
Population kinetics of an Ehrlich ascites tumor following treatment with methylglyoxal-bis(guanylhydrazone), a polyamine synthesis inhibitor.
1975
1975
Combination therapy with 5-azacytidine (NSC-102816) and methyl-GAG (NSC-32946) in previously treated adults with acute nonlymphocytic leukemia.
1975
1975
Combination therapy with 5-azacytidine (NSC-102816) and methyl-GAG (NSC-32946) in previously treated adults with acute nonlymphocytic leukemia.
1964
1964
METHYLGLYOXAL BIS(GUANYLHYDRAZONE), NSC-32946, 1 IN THE TREATMENT OF ACUTE MYELOBLASTIC AND MONOBLASTIC LEUKEMIA IN ADULTS.
1964
1964
METHYLGLYOXAL BIS(GUANYLHYDRAZONE), NSC-32946, 1 IN THE TREATMENT OF ACUTE MYELOBLASTIC AND MONOBLASTIC LEUKEMIA IN ADULTS.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)